Galactosylated pluronic potentiates the efficacy of p53 gene delivery for the treatment of hepatocellular carcinoma

摘要

These result suggest that introduction of galactose moiety to pluronic might contribute to the establishment of efficient gene therapy for hepatocellular carcinoma. This finding might be a next step forward in the evolution of liver cancer treatment and holds promise for clinical application.